EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Association Between Serum Remnant Cholesterol Level and Metabolic Dysfunction-associated Steatotic Liver Histology

Teruki Miyake iD, Shinya Furukawa, Bunzo Matsuura, Osamu Yoshida, Ayumi Kanamoto, Masumi Miyazaki, Akihito Shiomi, Hironobu Nakaguchi, Yuki Okazaki, Yoshiko Nakamura, Yusuke Imai, Mitsuhito Koizumi und 8 weitere

The Journal of Clinical Endocrinology & Metabolism · 19.05.2025 · 110 (6) · e2064-e2070

DOI: 10.1210/clinem/dgae597 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 28.08.2024. Verfasst von Teruki Miyake und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, 454 Shitsukawa, Toon City, Ehime 791-0295, Japan. Hauptthemen laut MEDLINE: Cholesterol, Fatty Liver, Triglycerides, Liver. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Estimated remnant cholesterol (Rem-C) level, a risk factor for cardiovascular disease, is associated with metabolic dysfunction-associated steatotic liver disease (MASLD) diagnosed via ultrasonography. However, the relationship between accurate serum Rem-C level measurements and histological findings of MASLD remains unclear.

Objective

We aimed to elucidate the relationship between accurately measured serum Rem-C levels and histological findings of MASLD.

Design

Cross-sectional single-center observational study.

Methods

We assessed 222 patients (94 men and 128 women; age 20-80) who were diagnosed with MASLD via liver biopsy with available medical history, physical examination, and biochemical measurement data. Serum ester-type cholesterol and free cholesterol contents in the remnant lipoproteins were measured using an enzymatic method.

Results

Serum Rem-C levels were significantly higher in patients with NAFLD activity score (NAS) 5 to 8, >66% steatosis grade, lobular inflammation with ≥5 foci, and many cells/prominent ballooning cells (a contiguous patch of hepatocytes showing prominent ballooning injury) than in patients with NAS 1 to 4, < 33% steatosis grade, lobular inflammation with <2 foci, and few ballooning cells (several scattered balloon cells), respectively. While univariate analysis revealed no significant association between Rem-C levels and advanced fibrosis, a significant association between Rem-C levels and NAS was evident. This relationship remained significant in multivariate analysis adjusted for confounders. Furthermore, in the analysis by sex, these relationships were significant for men but not for women.

Conclusion

High serum Rem-C levels were associated with high NAS but not with fibrosis stage, particularly in men. Controlling serum Rem-C level may improve MASLD activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholesterolFatty LiverTriglyceridesLiverNon-alcoholic Fatty Liver DiseaseLipoproteinsHumansMaleFemaleMiddle AgedCross-Sectional StudiesAdultAgedAged, 80 and overYoung AdultRisk Factors

Stichwörter der Autor:innen

NAFLD activity scorehistological findingmetabolic dysfunction-associated steatohepatitismetabolic dysfunction-associated steatotic liver diseaseremnant cholesterol

Substanzen

CholesterolTriglyceridesremnant-like particle cholesterolLipoproteins

Autor:innen und Institutionen

  • Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, 454 Shitsukawa, Toon City, Ehime 791-0295, Japan.
  • Health Services Center, Ehime University, 3 Bunkyocho, Matsuyama City, Ehime 790-0826, Japan.
  • Department of Lifestyle-related Medicine and Endocrinology, Ehime University Graduate School of Medicine, 454 Shitsukawa, Toon City, Ehime 791-0295, Japan.
  • Postgraduate Medical Education Center, Ehime University Graduate School of Medicine, 454 Shitsukawa, Toon City, Ehime 791-0295, Japan.

ORCID-Profile: Teruki Miyake

Förderung

  • JSPS KAKENHI

Zitieren

APA

Miyake, T., Furukawa, S., Matsuura, B., Yoshida, O., Kanamoto, A., Miyazaki, M., Shiomi, A., Nakaguchi, H., Okazaki, Y., Nakamura, Y., Imai, Y., Koizumi, M., Watanabe, T., Yamamoto, Y., Koizumi, Y., Tokumoto, Y., Hirooka, M., Kumagi, T., Abe, M., & Hiasa, Y. (2025). Association Between Serum Remnant Cholesterol Level and Metabolic Dysfunction-associated Steatotic Liver Histology. The Journal of Clinical Endocrinology & Metabolism, 110(6), e2064-e2070. https://doi.org/10.1210/clinem/dgae597

Vancouver

Miyake T, Furukawa S, Matsuura B, Yoshida O, Kanamoto A, Miyazaki M, et al. Association Between Serum Remnant Cholesterol Level and Metabolic Dysfunction-associated Steatotic Liver Histology. The Journal of Clinical Endocrinology & Metabolism. 2025;110(6):e2064-e2070. doi:10.1210/clinem/dgae597

BibTeX
@article{Miyake2025,
  author = {Miyake, Teruki and Furukawa, Shinya and Matsuura, Bunzo and Yoshida, Osamu and Kanamoto, Ayumi and Miyazaki, Masumi and Shiomi, Akihito and Nakaguchi, Hironobu and Okazaki, Yuki and Nakamura, Yoshiko and Imai, Yusuke and Koizumi, Mitsuhito and Watanabe, Takao and Yamamoto, Yasunori and Koizumi, Yohei and Tokumoto, Yoshio and Hirooka, Masashi and Kumagi, Teru and Abe, Masanori and Hiasa, Yoichi},
  title = {Association Between Serum Remnant Cholesterol Level and Metabolic Dysfunction-associated Steatotic Liver Histology},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  volume = {110},
  number = {6},
  pages = {e2064--e2070},
  doi = {10.1210/clinem/dgae597}
}
Kostenlos starten →